Bone marrow mesenchymal stem cells reduce intestinal ischemia/reperfusion injuries in rats

Journal of Surgical Research

Volumn 168, Issue 1, 2011, Pages 127-134

  Jiang, Haitao ^a,b   Qu, Linlin ^a,b   Li, Yun ^a   Gu, Lili ^b   Shi, Yichao ^a   Zhang, Jian ^c   Zhu, Weiming ^b   Li, Jieshou ^b  

^a NANJING UNIVERSITY   (China)

^b JINLING HOSPITAL   (China)

^c QINGDAO UNIVERSITY   (China)

Author keywords

intestine; ischemia reperfusion (I R); mesenchymal stem cells (MSCs); transplantation

Indexed keywords

SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY CLAMP; ARTICLE; BONE MARROW MESENCHYMAL STEM CELL; CONTROLLED STUDY; ENGRAFTMENT; FEMALE; HEMATOPOIETIC STEM CELL; IN SITU HYBRIDIZATION; INTESTINE INJURY; INTESTINE ISCHEMIA; INTESTINE MUCOSA PERMEABILITY; INTESTINE VILLUS; MALE; MESENCHYMAL STEM CELL; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SMALL INTESTINE; SPRAGUE DAWLEY RAT; SUPERIOR MESENTERIC ARTERY; Y CHROMOSOME;

ANIMALS; BONE MARROW TRANSPLANTATION; CELLS, CULTURED; CONSTRICTION; FEMALE; INTESTINE, SMALL; LACTATES; LACTULOSE; MALE; MANNITOL; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENTERIC ARTERY, SUPERIOR; MODELS, ANIMAL; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; TISSUE THERAPY;

EID: 79955636239     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2009.07.035     Document Type: Article

References (39)

1. Oldenburg WA, Lau LL, Rodenberg TJ, et al. Acute mesenteric ischemia: A clinical review. Arch Intern Med 2004;164:1054.
2. Abu-Elmagd K, Reyes J, Bond G, et al. Clinical intestinal transplantation: A decade of experience at a single center. Ann Surg 2001;234:404. discussion 416.
3. Quaedackers JS, Beuk RJ, Bennet L, et al. An evaluation of methods for grading histologic injury following ischemia/reperfusion of the small bowel. Transplant Proc 2000;32:1307.
4. Khanna A, Rossman J, Caty MG, et al. Beneficial effects of intraluminal nitroglycerin in intestinal ischemia-reperfusion injury in rats. J Surg Res 2003;114:15.
5. Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guineapig bone marrow and spleen cells. Cell Tissue Kinet 1970;3:393.
6. Kassem M, Kristiansen M, Abdallah BM. Mesenchymal stem cells: Cell biology and potential use in therapy. Basic Clin Pharmacol Toxicol 2004;95:209.
7. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002;418:41.
8. Devine SM, Cobbs C, Jennings M, et al. Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood 2003;101:2999.
9. Semont A, Francois S, Mouiseddine M, et al. Mesenchymal stem cells increase self-renewal of small intestinal epithelium and accelerate structural recovery after radiation injury. Adv Exp Med Biol 2006;585:19.
10. Ringden O, Uzunel M, Rasmusson I, et al. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 2006;81:1390.
11. Le BK, Rasmusson I, Sundberg B, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004;363:1439.
12. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006;98:1076.
13. Togel F, Weiss K, Yang Y, et al. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol 2007;292:F1626.
14. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143.
15. Smith JR, Pochampally R, Perry A, et al. Isolation of a highly clonogenic and multipotential subfraction of adult stem cells from bone marrow stroma. Stem Cells 2004;22:823.
16. Chiu CJ, Scott HJ, Gurd FN. Intestinal mucosal lesion in low-flow states. II. The protective effect of intraluminal glucose as energy substrate. Arch Surg 1970;101:484.
17. Demircan M, Cetin S, Uguralp S, et al. Plasma D-lactic acid level: A useful marker to distinguish perforated from acute simple appendicitis. Asian J Surg 2004;27:303.
18. Fleming SC, Kapembwa MS, Laker MF, et al. Rapid and simultaneous determination of lactulose and mannitol in urine, by HPLC with pulsed amperometric detection, for use in studies of intestinal permeability. Clin Chem 1990;36:797.
19. Behrens RH, Docherty H, Elia M, et al. A simple enzymatic method for the assay of urinary lactulose. Clin Chim Acta 1984;137:361.
20. Harting M, Jimenez F, Pati S, et al. Immunophenotype characterization of rat mesenchymal stromal cells. Cytotherapy 2008;10:243.
21. Kawada H, Fujita J, Kinjo K, et al. Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood 2004;104:3581.
22. Wang XJ, Li QP. The roles of mesenchymal stem cells (MSCs) therapy in ischemic heart diseases. Biochem Biophys Res Commun 2007;359:189.
23. Jin HK, Carter JE, Huntley GW, et al. Intracerebral transplantation of mesenchymal stem cells into acid sphingomyelinase-deficient mice delays the onset of neurological abnormalities and extends their life span. J Clin Invest 2002;109:1183.
24. Bae JS, Han HS, Youn DH, et al. Bone marrow-derived mesenchymal stem cells promote neuronal networks with functional synaptic transmission after transplantation into mice with neurodegeneration. Stem Cells 2007;25:1307.
25. Togel F, Hu Z, Weiss K, et al. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol 2005;289:F31.
26. Herrera MB, Bussolati B, Bruno S, et al. Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int J Mol Med 2004;14:1035.
27. Gao J, Dennis JE, Muzic RF, et al. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs 2001;169:12.
28. Zhang J, Gong JF, Zhang W, et al. Effects of transplanted bone marrow mesenchymal stem cells on the irradiated intestine of mice. J Biomed Sci 2008;15:585.
29. Nowicki PT, Nankervis CA. The role of the circulation in the pathogenesis of necrotizing enterocolitis. Clin Perinatol 1994;21:219.
30. Grant D, Wall W, Mimeault R, et al. Successful small-bowel/liver transplantation. Lancet 1990;335:181.
31. Deitch EA, Morrison J, Berg R, et al. Effect of hemorrhagic shock on bacterial translocation, intestinal morphology, and intestinal permeability in conventional and antibiotic-decontaminated rats. Crit Care Med 1990;18:529.
32. Deitch EA, Bridges W, Berg R, et al. Hemorrhagic shock-induced bacterial translocation: The role of neutrophils and hydroxyl radicals. J Trauma 1990;30:942. discussion 951.
33. Lin F, Cordes K, Li L, et al. Hematopoietic stem cells contribute to the regeneration of renal tubules after renal ischemia-reperfusion injury in mice. J Am Soc Nephrol 2003;14:1188.
34. Kale S, Karihaloo A, Clark PR, et al. Bone marrow stem cells contribute to repair of the ischemically injured renal tubule. J Clin Invest 2003;112:42.
35. Ortiz LA, Dutreil M, Fattman C, et al. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci U S A 2007;104:11002.
36. Zappia E, Casazza S, Pedemonte E, et al. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 2005;106:1755.
37. Alison MR, Lovell MJ, Direkze NC, et al. Stem cell plasticity and tumor formation. Eur J Cancer 2006;42:1247.
38. Majumdar MK, Thiede MA, Mosca JD, et al. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol 1998;176:57.
39. Haynesworth SE, Baber MA, Caplan AI. Cytokine expression by humanmarrow-derived mesenchymal progenitor cells in vitro: Effects ofdexamethasoneand IL-1alpha. JCellPhysiol 1996;166:585.